What is clinical endocannabinoid deficiency (CEDC)?

Top Answer

Medical Jane

Last updated: June 1st, 2016

Clinical endocannabinoid deficiency (CEDC) is a proposed spectrum disorder that has been implicated in a range of illnesses, including fibromyalgia, migraine and irritable bowel syndrome. So far, very little research has been conducted on this speculative disorder, but if it is found to exist, it could be responsible for these very common conditions and may respond favorably to cannabinoid therapies.

Click here to learn more.

Related Questions

Ask Jane a New Question

Have a question about the cannabis plant or its potential medical applications? Ask Jane by first searching Medical Jane’s database of frequently asked questions and answers. Chances are, someone has already asked and answered your question, so be sure to search Medical Jane before asking the Medical Jane community to answer your question.

Ask a new question


Thank you for subscribing!
There was a problem subscribing, please try again later.

Sign-up to receive the latest medical cannabis research, news, and special offers straight to your inbox.

By subscribing I agree to the Privacy Policy